Policies and Governance - test

At AAPS, we strive to create a community that will further our mission: to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health. We have created policies and a governance structure to support the pursuit of that mission, and we encourage you to read through the policies to understand more about AAPS.


The AAPS Bylaws document the basic rights, privileges and obligations of dues-paying members. The AAPS Bylaws also document the basic rules under which the organization will operate, including the authority of the Board of Directors to govern AAPS.

The AAPS membership approved the current Bylaws in February 2018. Any changes to the Bylaws require a 2/3 positive vote by those members who cast a ballot. 


Questions, comments or concerns on the AAPS Bylaws can be emailed to the Board of Directors.


Conflict of Interest Policy

This policy defines the terms and parties in a conflict of interest, and explains procedures that AAPS can take toward remedying conflicts of interest.


Privacy Policy

Information Collection, Disclosure, and Use:

This privacy statement demonstrates American Association of Pharmaceutical Scientists' ("AAPS") commitment to your right to privacy and explains the privacy policy governing the AAPS Portal site (the Web site). It is our general policy to collect and store only personal information that our members and visitors knowingly provide.

Areas of our site may require you to provide contact or other personally identifiable information, such as your name or e-mail address, which would only be used as described below. Unless otherwise provided, we may use the personal information we collect from you to ensure that our community is protected against unauthorized access, to use e-mail to diagnose problems with the server or to administer the Web Site, and to contact you when necessary. In addition, AAPS may sell, lease or otherwise provide the contact information you give in the membership application to third parties for pharmaceutical industry-related goods and services. AAPS shall permit such sale, lease or provision only (a) for a one-time use by the third party and (b) when AAPS has reviewed and approved the use by the third party.

AAPS collects cookies on our Web site to capture information about page visits. This information is anonymous and AAPS uses this information only internally - to deliver the most effective content to our visitors. Information from the cookies is used to gauge page opularity, analyze traffic patterns on our site and guide development of other improvements to our site. AAPS does not require that you accept cookies, however, some functionality on our Web site, our product or service check-out process, and products and services may be disabled if you decline to accept cookies. You can set your browser to notify you when you receive a cookie, giving you the chance to decide whether or not to accept it. You may also change your cookie settings through preferences options in our products and/or services, where applicable. AAPS never gives away information about our users. If you choose to e-mail us and provide personally identifiable information about yourself, AAPS will use this information only to respond to your inquiry. AAPS will not sell, rent or otherwise disclose that information to third parties unless such disclosure is necessary for the purposes set forth in this Policy, by law or a policy or notice contained or associated with a specific AAPS product or service.

AAPS uses analytics data and the DoubleClick cookie to serve ads based on a user's prior visits to our website.  Site visitors may opt out of the DoubleClick cookie by visiting the Google advertising opt-out page  or they may opt out of Google Analytics by visiting the  Google Analytics opt-out page.

Google has additional information available about their  Remarketing Privacy Guidelines,  Policies, and  Restrictions.

If our privacy policy changes, we will notify all users by a special announcement on the Web Site.


Minors, as defined by the jurisdiction from you are accessing this Web Site, are not permitted to subscribe to or use the Web Site.


If you do not want personally identifiable information that you provide on the Web Site's membership application to be disclosed to third parties as described above, you may opt out and elect not to have the information shared with third parties. AN OPT-OUT BOX WILL APPEAR WHEN YOU PROVIDE ANY REQUESTED INFORMATION.


Cookies are files that contain information created by a web server that can be stored on your hard disk for future use. Cookies are not used to disseminate significant information about you over the Internet or to analyze any information that you have knowingly or unknowingly provided. This Web Site uses cookies only to facilitate automated activity and to enable the server to recognize your computer.


This Web Site contains links to other web sites. We have no control over and are not responsible for the content, privacy policies or reliability of such sites.

Public Forums:

We may make various public forums and functions available to you. Any information you choose to share when using any of these forums or functions becomes public information. It is incumbent upon you to exercise caution in deciding whether to disclose any personal information.


We use encryption and other technology to store personal information gathered online in an attempt to provide a secure environment that is protected from unauthorized third party access, alteration, theft, or misuse.


You may change or modify information that you have already provided via phone toll free 1-877-998-AAPS within the U.S. and Canada, or +1 703-243-2800 from elsewhere.


Questions, concerns, or comments about this privacy policy, the practices of this website, or your dealings with this website?


Review of Opinions and Summary Reports Guideline

The American Association of Pharmaceutical Scientists (AAPS) has established a position of leadership among pharmaceutical scientists such that the opinions of AAPS groups and summary reports from AAPS-sponsored events may be disseminated. This guideline provides a general framework by which such opinions should be communicated, posted, or published, and the process by which the association will review such items for approval.


Intent of the Guideline

The scientific content of opinions by AAPS groups, or of summary reports from AAPS-sponsored events, is not the specific purview of AAPS. But to ensure that such reports reflect the majority of scientific views on the topic being discussed or described, it is the specific charge of the AAPS Executive Council to ensure that an appropriate process has been followed to achieve scientific consensus.


This guideline details the process to ensure the content represents a viewpoint that is expressed by the majority of the authoring body, and reflects the general scientific views of association members.


Guideline for Development

  1. This guideline covers workshop reports, consensus documents, white papers, books, chapters, or any other written item that is intended to summarize the major findings and content of an opinion generated by an AAPS group or summarize the findings and content of an AAPS-sponsored event. This guideline applies to any group sponsored in whole or in part by AAPS, and applies to any event sponsored in whole or in part by AAPS.


  1. The purpose of these items should be to represent the best-founded scientific data and majority opinion of the scientists of the association. The content must be based upon the data and opinions formed during discussion at AAPS group meetings and events and not of an individual or select subgroup of individuals. Proceedings or compilations of scientific information by individual author(s) and contributor(s) do not fall under this guideline.


  1. This guideline should be distributed to all members of the organizing committee at the outset of planning for any event or at the outset of any group deliberation. AAPS agreements to cosponsor a group or an event should state the requirement for AAPS to follow this guideline on any summary report or opinion.


  1. The document should be written by the organizing committee of the event or a core group of participants in the forum from which the opinion emanates. An appropriate acknowledgment of all key contributors must be included in the work.


  1. To the extent possible, prior to AAPS events or group meetings where an opinion or report is likely or is planned, group members who will write and review the item should be designated.


  1. When feasible and in the best interest of the target audience, AAPS journals should be designed as the preferred vehicle for dissemination.


  1. The summary report or opinion should have one key individual identified as the corresponding author. But a group of key individuals should be identified with expertise in the scientific area of specialty. These should include, when applicable, the participants from the event or group process and key scientists knowledgeable in the specific area.


  1. The report or opinion should be widely distributed in draft form to a number of different individuals to be sure that all perspectives of AAPS are represented. In particular, the draft document should be sent to the chair of any AAPS Section, Committee, Discussion Group, or Focus Group within the scope of the general knowledge and review of the scientific content. A reasonable timeframe for review must be allowed: at least one week but generally not more than three weeks. A list should be prepared of people who participated in the writing and the review of the report/opinion.


Guideline for AAPS Review

  1. A review form should be submitted with the final draft of the document for approval.


  1. If the document is to be published in a peer-reviewed scientific journal, the corresponding author should submit it to an AAPS journal or, if to a non-AAPS journal, first to the AAPS director of publications. If the document is to be published, disseminated, or communicated other than in a peer-reviewed scientific journal, such as a website open for public comment, then the principal contact should submit it to the AAPS director of public outreach.


  1. If the document is submitted to an AAPS journal, the responsibility to judge its suitability for dissemination rests entirely with that journal’s editor-in-chief, who may choose to consult with experts in the field, the chair of the Publications Committee, or the Executive Council, if appropriate. The decision and any feedback will go from the editor-in-chief to the corresponding author.


  1. If the document is to be submitted to a non-AAPS journal, the AAPS director of publications will submit the document to the AAPS Executive Council for review and approval, and will convey the decision and any feedback to the corresponding author.


  1. If the document is to be published, disseminated, or communicated other than in a peer-reviewed scientific journal, the AAPS director of public outreach will submit the document to the appropriate AAPS section(s) or, if deemed necessary based on subject matter or content, the Executive Council for review and approval based on AAPS guidelines. Once finalized, the document will be submitted by AAPS staff to the appropriate venue. The comments will then be included as an informational item for the AAPS Executive Council at their next meeting or teleconference call, whichever comes first.


  1. Submitters are encouraged, but not required, to provide a summary of their comments for inclusion in the AAPS online newsmagazine.

Code of Ethics

AAPS member scientists recognize their special obligations to society and the public welfare.  They use their expertise with integrity to advance the health and welfare of mankind.  In their scientific pursuits they:


  • Conduct their work in a manner that adheres to the highest principles of scientific research so as to merit the confidence and trust of peers and the public in particular regarding the rights of human subjects and concern for the proper use of animals involved and provision for suitable safeguards against environmental damage.
  • Avoid scientific misconduct and expose it when encountered. AAPS uses the current federal definition of scientific misconduct, 65 FR 76260-76264:  Fabrication, falsification, and plagiarism in proposing, performing, or reviewing research or reporting research results.
  • Recognize latitude for differences of scientific opinion in the interpretation of scientific data and that such differences of opinion do not constitute unethical conduct.
  • Disclose sources of external financial support for, or significant financial interests in the content of, research reports/publications and avoid the manipulation of the release of such information for illegal financial gain.
  • Report results accurately, stating explicitly any known or suspected bias, opposing efforts to improperly modify data or conclusions an offering professional advice only on those subjects concerning which they regard themselves competent through scientific education, training or experience.
  • Respect the known ownership rights of others in scientific research and seek prior authorization from the owner before disclosure or use of such information including the contents of manuscripts submitted for pre-publication review.
  • Support in their research and among their employers the participation and employment of all qualified persons regardless of race, gender, creed or national origin.





Budgeting/Investment Policy

Intermediate-term Investment Policy

AAPS’ investment policy statement reflects the investment policy, objectives, and constraints of the organization. This statement was originally adopted on January 1, 1998, revised on February 23, 2007, and revised subsequently on April 15, 2012. AAPS’ IPS is set forth by the Finance Committee with approval by the Board of Directors.

View the investment policy:
Investment Policy, long-term (PDF)

Long-term Investment Policy

AAPS’ investment policy statement reflects the investment policy, objectives, and constraints of the organization’s Intermediate Reserve. The Intermediate Reserve has a time horizon and investment objectives that differ from the organization’s Long-Term Reserve and therefore, these two reserves shall remain separate and distinct.
This statement was adopted on November 11, 2013. The Intermediate Reserve’s IPS is set forth by the Finance Committee with approval by the Board of Directors.

View the investment policy:
Investment Policy, intermediate term (PDF)

Volunteer Travel Policy

Travel Support and Reimbursement
AAPS offers travel support with the goal of bringing the best possible scientific knowledge to an event.
This philosophy applies to all AAPS programs including PharmSci 360, webinars, workshops, etc.

AAPS uses a variety of strategies to support speakers’ participation in events. To understand how AAPS
approaches the use of its resources, read the following information closely. All travel support and
reimbursement opportunities will be determined during the business-planning process by staff and
are subject to limitations and individual confirmation prior to any event.

Whether travelships are appropriate for an event, and the qualifications for them and method of
distribution, is determined by staff during the business-planning process. They must fill a critical need to
bring science to a meeting, and must be reasonable and financially sustainable based on the event size
and audience demographic. Travelships are not an option for every event.

Speaker Reimbursement
AAPS recognizes that volunteer time and contributions are vital to our organization’s success and we
highly value the leaders who help us advance our mission.

As a non-profit organization, AAPS is unable to provide full travel reimbursement and full conference
complimentary registrations to all volunteers. Only AAPS Staff can approve, manage, and allocate
funding for reimbursement and this will be communicated prior to the event. 


Media Policy

The AAPS media and recording policy addresses the circumstances under which photography and recording are permitted or restricted.

AAPS Community operating conditions are available on the AAPS Community website.

The following information is included:
  • Code of Conduct
  • Terms of Use
  • Etiquette